Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Molecular Neurodegeneration
Published in: Molecular Neurodegeneration 1/2016

Open Access 01-12-2016 | Erratum

Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay

Authors: Wendy E. Heywood, Daniela Galimberti, Emily Bliss, Ernestas Sirka, Ross W. Paterson, Nadia K. Magdalinou, Miryam Carecchio, Emma Reid, Amanda Heslegrave, Chiara Fenoglio, Elio Scarpini, Jonathan M. Schott, Nick C. Fox, John Hardy, Kailash P. Bhatia, Simon Heales, Neil J. Sebire, Henrik Zetterberg, Kevin Mills

Published in: Molecular Neurodegeneration | Issue 1/2016

Login to get access

Excerpt

After publication of this work [1], we noted that the names of two authors Kailash Bhatia and Henrik Zetterberg had been misspelled. The names have now been corrected above. …
Literature
1.
Heywood WE, Galimberti D, Bliss E, Sirka E, Paterson RW, Magdalinou NK, et al. Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay. Mol Neurodegener. 2015;10:64. Epub 2015/12/03.PubMedCentralCrossRefPubMed
Metadata
Title
Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay
Authors
Wendy E. Heywood
Daniela Galimberti
Emily Bliss
Ernestas Sirka
Ross W. Paterson
Nadia K. Magdalinou
Miryam Carecchio
Emma Reid
Amanda Heslegrave
Chiara Fenoglio
Elio Scarpini
Jonathan M. Schott
Nick C. Fox
John Hardy
Kailash P. Bhatia
Simon Heales
Neil J. Sebire
Henrik Zetterberg
Kevin Mills
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Molecular Neurodegeneration / Issue 1/2016
Electronic ISSN: 1750-1326
DOI
https://doi.org/10.1186/s13024-016-0086-3

Other articles of this Issue 1/2016

Molecular Neurodegeneration 1/2016 Go to the issue

Review

Induced pluripotent stem cells in Alzheimer’s disease: applications for disease modeling and cell-replacement therapy

Research article

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease

Research article

Pioglitazone ameliorates the phenotype of a novel Parkinson’s disease mouse model by reducing neuroinflammation

Research article

Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson’s Disease

Research article

Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson’s disease

Research article

Chronic adiponectin deficiency leads to Alzheimer’s disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice